CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CASH FLOW FROM OPERATING ACTIVITIES
Net loss	$ (4,519,949)	$ (3,266,013)	$ (2,582,537)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization	160,625	160,625	185,271
Depreciation	10,284	0	0
Technology impairment	0	0	345,000
Common stock issed for services	0	0	18,500
Stock options and warrants	404,150	704,480	63,385
(Increase) decrease in assets
Prepaid drug product for testing	(103,303)	143,636	(42,000)
Other current assets	(36,377)	(21,542)	5,864
Increase (decrease) in liabilities
Accounts payable and accrued expenses	267,073	(34,346)	13,113
Net cash used in operating activities	(3,817,497)	(2,313,160)	(1,993,404)
CASH FLOW FROM INVESTING ACTIVITIES
Purchase of exclusive license - related party	0	0	(25,000)
Purchase furniture, fixtures & equipment	(123,410)	0	0
Net cash used in investing activities	(123,410)	0	(25,000)
CASH FLOW FROM FINANCING ACTIVITIES
Net proceeds from sale of common stock	13,812,373	5,330,946	1,600,198
Net proceeds from exercise of common stock options	435,500	0	0
Net cash from financing activities	14,247,873	5,330,946	1,600,198
NET INCREASE (DECREASE) IN CASH	10,306,966	3,017,786	(418,206)
Cash, beginning of period	3,551,832	534,046	952,252
Cash, end of period	13,858,798	3,551,832	534,046
Cash paid for
Interest	0	0	0
Income taxes	0	0	0
Non-cash financing activities
Common stock issued to Placement Agent	0	771,047	0
Due diligence and commitment shares issued	$ 0	$ 0	$ 1,750